Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham R Foster

Showing results (61-70 of 191) with videos related to

Pageof 20
Sort By:
European Journal of Public Health|June 29, 2011
Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesisRoss J Harris, Mary Ramsay, Vivian D Hope, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populationsNatasha K Martin, Peter Vickerman, Alec Miners, et al.
Cytokine|May 7, 2002
Different activities of type I interferons on hepatitis B virus core promoter regulated transcriptionEwert Schulte-Frohlinde, Barbara Seidler, Ines Burkard, et al.
United European Gastroenterology Journal|June 12, 2014
A cross sectional study of colonic diverticulosis in the London Bangladeshi populationRajiv P Lahiri, Aliza Abeles, Katherine M Burnand, et al.
Hepatology (Baltimore, Md.)|October 21, 2014
Development and validation of a "capture-fusion" model to study drug sensitivity of patient-derived hepatitis CMorven E Cunningham, Alia Javaid, Jenny Waters, et al.
Plos One|January 3, 2019
Safety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or olderGraham R Foster, Tarik Asselah, Sarah Kopecky-Bromberg, et al.
Blood Advances|June 23, 2023
Molecular evaluation and vector integration analysis of HCC complicating AAV gene therapy for hemophilia BManfred Schmidt, Graham R Foster, Michiel Coppens, et al.
Journal of Hepatology|September 2, 2015
Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin useJessica K Dyson, John Hutchinson, Laura Harrison, et al.
European Journal of Gastroenterology & Hepatology|August 5, 2016
Community nurse-led initiation of antiviral therapy for chronic hepatitis C in people who inject drugs does not increase uptake of or adherence to treatmentHeather Lewis, Jan Kunkel, David Axten, et al.
Pulmonary Circulation|February 2, 2013
Endothelin-1 as a mediator and potential biomarker for interferon induced pulmonary toxicityPeter M George, Morven E Cunningham, Neil Galloway-Phillipps, et al.
Pageof 20

Showing results (61-70 of 191) with videos related to

Sort By:
Pageof 20
European Journal of Public Health|June 29, 2011
Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesisRoss J Harris, Mary Ramsay, Vivian D Hope, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populationsNatasha K Martin, Peter Vickerman, Alec Miners, et al.
Cytokine|May 7, 2002
Different activities of type I interferons on hepatitis B virus core promoter regulated transcriptionEwert Schulte-Frohlinde, Barbara Seidler, Ines Burkard, et al.
United European Gastroenterology Journal|June 12, 2014
A cross sectional study of colonic diverticulosis in the London Bangladeshi populationRajiv P Lahiri, Aliza Abeles, Katherine M Burnand, et al.
Hepatology (Baltimore, Md.)|October 21, 2014
Development and validation of a "capture-fusion" model to study drug sensitivity of patient-derived hepatitis CMorven E Cunningham, Alia Javaid, Jenny Waters, et al.
Plos One|January 3, 2019
Safety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or olderGraham R Foster, Tarik Asselah, Sarah Kopecky-Bromberg, et al.
Blood Advances|June 23, 2023
Molecular evaluation and vector integration analysis of HCC complicating AAV gene therapy for hemophilia BManfred Schmidt, Graham R Foster, Michiel Coppens, et al.
Journal of Hepatology|September 2, 2015
Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin useJessica K Dyson, John Hutchinson, Laura Harrison, et al.
European Journal of Gastroenterology & Hepatology|August 5, 2016
Community nurse-led initiation of antiviral therapy for chronic hepatitis C in people who inject drugs does not increase uptake of or adherence to treatmentHeather Lewis, Jan Kunkel, David Axten, et al.
Pulmonary Circulation|February 2, 2013
Endothelin-1 as a mediator and potential biomarker for interferon induced pulmonary toxicityPeter M George, Morven E Cunningham, Neil Galloway-Phillipps, et al.
Pageof 20